Form D · Biotechnology
NeurOp, Inc.
Atlanta, GA · CIK 0001600607
Offering snapshot reported Feb 24, 2014 · SEC filing
- Reported sold
- $155K Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 24, 2014 | Initial | $155,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212365
Source: Form D, filed Feb 24, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Bonczek | Director |
| Raymond Dingledine | Director |
| George Koszalka | Director, Executive |
| Dennis Liotta | Director |
| James Mc Namara | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
58 Edgewood Avenue, Ne Collabtech, First Floor, Suite 117
Atlanta, GA, 30303
Atlanta, GA, 30303